The Clorox Company (CLX)
NYSE: CLX · Real-Time Price · USD
93.80
-1.96 (-2.05%)
At close: Jul 23, 2026, 4:00 PM EDT
93.85
+0.05 (0.05%)
After-hours: Jul 23, 2026, 7:45 PM EDT

The Clorox Company Earnings Call Transcripts

Fiscal Year 2026

  • Leadership transition is underway with no immediate operational changes. The business is stabilizing after a major ERP upgrade, focusing on innovation and market share gains amid a volatile consumer environment. GOJO integration is progressing well, with financial discipline and digital transformation supporting future growth.

  • Q3 results were mixed, with gross margin pressured by higher supply chain costs and delayed savings. ERP implementation is complete, innovation is strong in key segments, and the GOJO acquisition is expected to be accretive despite near-term margin dilution. Elevated input costs and inflation remain key risks.

  • ERP implementation is complete, setting the stage for improved execution and innovation. Category growth is expected to remain flat to 1%, with strong innovation and the GOJO acquisition driving future momentum. Margin expansion and productivity gains are anticipated, with deleveraging and disciplined capital allocation in focus.

  • Digital transformation and portfolio modernization have rebuilt margins and positioned for growth. Consumer insights drive innovation, with new platforms like Clorox Pure and Scentiva expanding reach. The GOJO acquisition will boost Health and Hygiene, supporting long-term profitable growth.

  • Q2 results met expectations amid macro and ERP challenges, with sequential improvement and early share gains. Gross margin is set to expand in H2 as ERP costs subside, and major innovation launches are expected to drive growth. The GOJO acquisition will further strengthen health and hygiene leadership.

  • M&A announcement

    The acquisition of Gojo Industries for $2.25 billion strengthens leadership in health and hygiene, leveraging Purell's market position and recurring B2B revenue. The deal is expected to deliver at least $50 million in cost synergies, be EPS neutral in year one, and accretive in year two, with a disciplined integration plan and strong long-term growth prospects.

  • ERP system launch drove operational transformation but caused temporary sales and share headwinds. Guidance anticipates a return to growth in the back half, supported by innovation, improved gross margin outlook, and targeted investments. Consumer volatility and competitive pressures persist.

Fiscal Year 2025

  • U.S. consumers are value-focused, driving flat category growth, while innovation and digital investments are set to boost performance. Margin management, targeted investments, and a strong brand pipeline support confidence in growth and profitability for the coming years.

  • Margin and earnings outperformed expectations despite sales challenges, as digital transformation and ERP implementation progressed. Innovation is accelerating with new platforms and AI-driven insights, while brand superiority and strategic promotions are key to regaining share. ERP-related sales declines are temporary, with sequential improvement and margin expansion expected in the back half.

  • Fiscal 2025 ended with strong margins but weaker sales, impacted by ERP-related inventory builds and a dynamic consumer environment. FY26 guidance calls for flat to modest organic growth, stable margins, and continued investment in innovation and digital transformation, with ERP timing noise expected to subside by FY27.

  • Consumer value-seeking and tariff-driven volatility have impacted category growth, but essentials remain resilient. Digital and margin transformation, including a major ERP rollout, are set to drive future productivity, with most benefits expected in FY27-28. Innovation and disciplined capital allocation underpin long-term growth.

  • Gross margin expanded for the 10th straight quarter despite weaker consumer sentiment and volatile sales. Q4 will see ERP-driven inventory build and tariff impacts, but stable margins and strong brand performance are expected.

  • A comprehensive transformation has modernized operations, accelerated innovation, and enhanced personalization, positioning the company for sustained top-line growth and margin expansion. Financial targets include 3%-5% sales growth and consistent EBIT margin gains, with strong cash flow and disciplined capital deployment.

  • Leadership transition to new CFO, ERP implementation, and full Glad control mark a transformative year. Q2 organic sales outperformed guidance, gross margin recovery on track, and long-term growth targets reaffirmed despite ongoing competitive and macro challenges.

  • Q1 delivered strong organic sales and gross margin growth, with full restoration of market share and supply post-cyberattack. Guidance for FY25 remains at 4% organic growth, with gross margin expected to return to pre-pandemic levels. Promotional activity and consumer value-seeking continue to shape the outlook.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020